LMLLF (Pharmadrug) Effective Interest Rate on Debt %: 24.27% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Pharmadrug Effective Interest Rate on Debt %?

Pharmadrug LMLLF Effective Interest Rate on Debt % is 24.27% as of Mar. 2026. The stock has 1 warning sign investors should review.

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Pharmadrug's annualized positive value of Interest Expense for the quarter that ended in Mar. 2026 was $0.28 Mil. Pharmadrug's average total debt for the quarter that ended in Mar. 2026 was $1.14 Mil. Therefore, Pharmadrug's annualized Effective Interest Rate on Debt % for the quarter that ended in Mar. 2026 was 24.27%.


Pharmadrug  (OTCPK:LMLLF) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.


Pharmadrug Effective Interest Rate on Debt % Related Terms


Pharmadrug Effective Interest Rate on Debt % Historical Data

* Premium members only.

The historical data trend for Pharmadrug's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmadrug Effective Interest Rate on Debt % Chart

Pharmadrug Annual Data
Trend Sep16 Sep17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Effective Interest Rate on Debt %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.04 24.46 21.07 16.96 21.97

Pharmadrug Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Effective Interest Rate on Debt % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.51 15.92 15.05 39.30 24.27

LMLLF vs ZTS: Effective Interest Rate on Debt % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Pharmadrug's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharmadrug Effective Interest Rate on Debt % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pharmadrug's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where Pharmadrug's Effective Interest Rate on Debt % falls into.



Pharmadrug Effective Interest Rate on Debt % Calculation

Pharmadrug's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Dec. 2025 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (A: Dec. 2024 )+Total Debt  (A: Dec. 2025 ))/ count )
=-1  *  -0.225/( (0.947+1.101)/ 2 )
=-1  *  -0.225/1.024
=21.97 %

where

Pharmadrug's annualized Effective Interest Rate on Debt % for the quarter that ended in Mar. 2026 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (Q: Dec. 2025 )+Total Debt  (Q: Mar. 2026 ))/ count )
=-1  *  -0.276/( (1.101+1.173)/ 2 )
=-1  *  -0.276/1.137
=24.27 %

where

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is four times the quarterly (Mar. 2026) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.

What does a Effective Interest Rate on Debt % of 24.27% mean?
Pharmadrug (LMLLF) has a Effective Interest Rate on Debt % of 24.27% as of Mar. 2026. Effective interest rate on debt is the rate a company actually pays on its debt. View historical data on Pharmadrug and its competitors.
Is Pharmadrug's Effective Interest Rate on Debt % too high?
Pharmadrug's current Effective Interest Rate on Debt % is 24.27%.
How does Pharmadrug's Effective Interest Rate on Debt % compare to ZTS?
Pharmadrug's Effective Interest Rate on Debt % of 24.27% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Effective Interest Rate on Debt % for a Drug Manufacturers company?
A good Effective Interest Rate on Debt % depends on the Drug Manufacturers industry context. However, Effective Interest Rate on Debt % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Effective Interest Rate on Debt % mean?
A high Effective Interest Rate on Debt % can signal that a stock is expensive relative to its fundamentals. Effective interest rate on debt is the rate a company actually pays on its debt. View historical data on Pharmadrug and its competitors. Pharmadrug's current Effective Interest Rate on Debt % is 24.27%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharmadrug stock overvalued right now?
Based on GuruFocus' analysis, Pharmadrug (LMLLF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.04, compared to a current price of $0.01 — trading 84.4% below its estimated fair value. The current Effective Interest Rate on Debt % is 24.27%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Effective Interest Rate on Debt % calculated?
Effective Interest Rate on Debt % is calculated from a company's financial statements. For Pharmadrug (LMLLF), the current Effective Interest Rate on Debt % is 24.27% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Pharmadrug Business Description

Other Exchanges PHRX:Canada
Address 130 Adelaide Street West, Suite 3002, Toronto, ON, CAN, M5K 1H1
Pharmadrug Inc is a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics and naturally derived approved drugs. The company's operations comprise of the corporate division in Canada.